Report: Developing Opportunities within Louisiana-Pacific, Neurocrine Biosciences, Tahoe Resources, Loews, Quotient Technology, and Evolent Health — Future Expectations, Projections Moving into 2018

World News: . []

NEW YORK, Nov. 09, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Louisiana-Pacific Corporation (NYSE:LPX), Neurocrine Biosciences, Inc. (NASDAQ:NBIX), Tahoe Resources, Inc. (NYSE:TAHO), Loews Corporation (NYSE:L), Quotient Technology Inc. (NYSE:QUOT), and Evolent Health, Inc (NYSE:EVH), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

The new research reports from Market Source Research, available for free download at the links above, examine Louisiana-Pacific Corporation (NYSE:LPX), Neurocrine Biosciences, Inc. (NASDAQ:NBIX), Tahoe Resources, Inc. (NYSE:TAHO), Loews Corporation (NYSE:L), Quotient Technology Inc. (NYSE:QUOT), and Evolent Health, Inc (NYSE:EVH) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

-----------------------------------------

For the three months ended September 30th, 2018 vs September 30th, 2017, Louisiana-Pacific reported revenue of $736.80MM vs $718.30MM (up 2.58%) and analysts estimated basic earnings per share $0.87 vs $0.76 (up 14.47%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Louisiana-Pacific reported revenue of $2,733.90MM vs $2,233.40MM (up 22.41%) and analysts estimated basic earnings per share $2.70 vs $1.04 (up 159.62%). Analysts expect earnings to be released on February 12th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $0.73. The estimated EPS forecast for the next fiscal year is $2.18 and is expected to report on February 12th, 2019.

To read the full Louisiana-Pacific Corporation (LPX) report, download it here:

-----------------------------------------

For the three months ended September 30th, 2018 vs September 30th, 2017, Neurocrine Biosciences reported revenue of $151.76MM vs $60.77MM (up 149.71%) and analysts estimated basic earnings per share $0.56 vs -$0.13. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Neurocrine Biosciences reported revenue of $161.63MM vs $15.00MM (up 977.51%) and analysts estimated basic earnings per share -$1.62 vs -$1.63. Analysts expect earnings to be released on February 12th, 2019. The report will be for the fiscal period ending December 31st, 2018. Reported EPS for the same quarter last year was $0.07. The estimated EPS forecast for the next fiscal year is $1.79 and is expected to report on February 12th, 2019.

To read the full Neurocrine Biosciences, Inc. (NBIX) report, download it here:

-----------------------------------------

For the three months ended June 30th, 2018 vs June 30th, 2017, Tahoe Resources reported revenue of $127.13MM vs $209.58MM (down 39.34%) and analysts estimated basic earnings per share -$0.05 vs $0.11. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Tahoe Resources reported revenue of $733.56MM vs $784.50MM (down 6.49%) and analysts estimated basic earnings per share $0.26 vs $0.41 (down 36.59%). Analysts expect earnings to be released on February 28th, 2019. The report will be for the fiscal period ending December 31st, 2018. Reported EPS for the same quarter last year was -$0.06. The estimated EPS forecast for the next fiscal year is $0.23 and is expected to report on February 28th, 2019.

To read the full Tahoe Resources, Inc. (TAHO) report, download it here:

-----------------------------------------

For the three months ended September 30th, 2018 vs September 30th, 2017, Loews reported revenue of $3,608.00MM vs $3,521.00MM (up 2.47%) and basic earnings per share $0.88 vs $0.46 (up 91.30%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Loews reported revenue of $13,735.00MM vs $13,105.00MM (up 4.81%) and analysts estimated basic earnings per share $3.46 vs $1.93 (up 79.27%). Analysts expect earnings to be released on February 11th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $0.83. The estimated EPS forecast for the next fiscal year is $3.80 and is expected to report on February 11th, 2019.

To read the full Loews Corporation (L) report, download it here:

-----------------------------------------

For the three months ended June 30th, 2018 vs June 30th, 2017, Quotient Technology reported revenue of $89.55MM vs $74.49MM (up 20.21%) and analysts estimated basic earnings per share -$0.05 vs -$0.06. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Quotient Technology reported revenue of $322.12MM vs $275.19MM (up 17.05%) and analysts estimated basic earnings per share -$0.17 vs -$0.23. Analysts expect earnings to be released on February 12th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $0.06. The estimated EPS forecast for the next fiscal year is $0.11 and is expected to report on February 12th, 2019.

To read the full Quotient Technology Inc. (QUOT) report, download it here:

-----------------------------------------

For the three months ended June 30th, 2018 vs June 30th, 2017, Evolent Health reported revenue of $144.30MM vs $107.07MM (up 34.77%) and analysts estimated basic earnings per share -$0.13 vs -$0.28. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Evolent Health reported revenue of $434.95MM vs $254.19MM (up 71.11%) and analysts estimated basic earnings per share -$0.94 vs -$3.55. Analysts expect earnings to be released on February 26th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was -$0.10.

To read the full Evolent Health, Inc (EVH) report, download it here:

-----------------------------------------

Market Source Research delivers the key research reports that helps serious investors, registered brokers, professional traders, and personal investment advisers find reliable information in today's markets. Market Source Research's team is comprised of financial professionals, many of which hold Chartered Financial Analyst® (CFA®) designations and FINRA® BrokerCheck® certifications. Whether identifying emerging trends, or discovering new opportunity, the team at Market Source Research is dedicated to providing accurate, informative, and objective content that's ahead of the curve. With insights on individual companies as well as sectors, readers get the industry's best available combination of big-picture perspective as well as granular detail.

Market Source Research's oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Market Source Research's roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Market Source Research have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Market Source Research's Compliance department by Phone, at +1 (704) 343-6361, or by E-mail at compliance@MarketSourceResearch.com.

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Market Source Research, Market Source Research members, and/or Market Source Research affiliates are not responsible for any gains or losses that result from the opinions expressed. Market Source Research makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Market Source Research has not been compensated for the publication of this press release by any of the above mentioned companies. Market Source Research is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

More news and information about Market Source Research

Published By:

Globe Newswire: 13:30 GMT Friday 9th November 2018

Published: .

Search for other references to "report" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us